Previous 10 | Next 10 |
Biotricity Inc. (BTCY) is expected to report $-0.34 for Q2 2024
Biotricity improves margins while lowering selling expenses and operating losses REDWOOD CITY, CA / ACCESSWIRE / November 10, 2023 / Biotricity Inc. (Nasdaq:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of con...
2023-11-07 07:31:46 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time for another dive into the biggest pre-market stock movers as we break down all of the latest news for Tuesday morning. Moving stocks are earnings reports, clinical trial re...
Company further expands its current product portfolio, making it the most comprehensive Remote Patient and Cardiac Monitoring portfolio globally. Company developed Biotres Pro with critical capability of cellular backup for connectivity Recently filed a patent application for its Biotre...
2023-10-27 13:45:10 ET Gainers: Forbion European Acquisition Corp ( FRBN ) +103% . Spectaire Holdings ( SPEC ) +40% . Nerdwallet ( NRDS ) +38% . Integrated Media Technology Limited ( IMTE ) +34% . Envoy Medical ( COCH ) +25% . ...
2023-10-27 10:02:45 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector as earnings close in BofA reports 10th consecutive week of equity inflows For further detail...
REDWOOD CITY, CA / ACCESSWIRE / October 10, 2023 / Biotricity, Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitoring sector of consumer healthcare, today announced its patent filing for the company's Bioheart device. Bioheart, regarded as one of ...
This release corrects and replaces the headline in the the release that was disseminated October 3, 2023. The reason for this correction is to fix the title which previously stated "patient" rather than the correct word, "PATENT" REDWOOD CITY, CA / ACCESSWIRE / October 4, 2023 / Biotrici...
REDWOOD CITY, CA / ACCESSWIRE / October 3, 2023 / Biotricity, Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced the filing of a patent application for its groundbreaking Biotres device. This patent ...
Biotricitys New Digital Presence Reflects Commitment to Innovation in the Healthcare Space. REDWOOD CITY, CA / ACCESSWIRE / September 13, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcare technology company, announc...
News, Short Squeeze, Breakout and More Instantly...
Democratizing cardiac health with convenient, rapid, and reliable results REDWOOD CITY, CA / ACCESSWIRE / June 28, 2024 / Biotricity Inc. (NASDAQ:BTCY), a forerunning Technology-as-a-Service (TaaS) company committed to disrupting the healthcare industry with cutting-edge medical and consume...
FY24 revenue up 25.2% YOY FY24 margins improved 1280 basis points to 69.3%, from 56.5% in the prior year; Q4-FY24 margins improved to 71.5%; margin expansion forecasted to continue FY24 operating expenses lower by 17.6% YOY Negative EBITDA reduced by $7.2 million - an improvement o...
REDWOOD CITY, CA / ACCESSWIRE / June 12, 2024 / Biotricity Inc. (NASDAQ:BTCY), a forerunning Technology-as-a-Service (TaaS) company committed to disrupting the healthcare industry with cutting-edge medical and consumer diagnostic solutions, today announces the highly anticipated launch of its di...